header photo San Clemente 9/10/2021 2:09:49 PM
News / Business

GWHP Corp Continues to Supply PPE Supplies and COVID-19 Tests As COVID-19 Cases Surge

COVID-19 cases are on the climb, especially due to the contagious Delta Variant. Global WholeHealth Partners stands committed to sourcing and supplying in demand COVID-19 diagnostic testing kits and personal protective equipment to help keep you safe. We offer these products in large wholesale quantities and interested parties can visit our medical supply page to view current inventory levels. At this time, we can only do our best to protect ourselves and others by following recommended social distancing guidelines and PPE recommendations.

We are incredibly thankful and hopeful that the Pfizer, Moderna and other major vaccines are making their way to millions of people across the globe. However, continued use of PPE supplies will help slow the spread of the virus so we can end this pandemic. We all can do our part to help slow the spread of COVID-19 by social distancing where we can, staying quarantined when we are sick, and using PPE supplies when leaving the house. Masks wearing is required in most public indoor places such as shopping malls, grocery stores and restaurants and often times negative COVID-19 tests are required for travel.

Get in touch with Global WholeHealth Partners now to place your order for wholesale PPE supplies or wholesale COVID-19 testing kits, or both, depending on your needs. We continue to source and supply these in demand products for our customers across the country. Call 877-568-4947 to start your order now.

About Global WholeHealth Partners OTC (GWHP)
GWHP provides cutting edge technology using In-vitro Diagnostic (IVD) Real-Time PCR Machines that detect between 1 - 1 ½ hours and Rapid Diagnostic Testing (RDT) Serum Plasma that detect between 15 -20 minutes, which predict diseases ahead of its industry competitors. Our focus is encompassing, improving, and preserving the quality of life by providing fast, adequate and accurate test results to prompt early treatment and cut cost of accumulated diseases all over the world. By so doing, GWHP has led the fight against vector borne terminal diseases such as Ebola, ZIKA, Dengue, Malaria, Influenza and Tuberculosis, Corona Viruses, and among other vector borne diseases. MISSION GWHP is committed to building long term shareholder value through the vertical integration of proven, well established business that effectively and efficiently control disease outbreak and significantly reducing health care costs. VISION Our vision is to lead the industry in infectious disease diagnostics and provide molecular solutions that lessen the time to diagnose medical results, empower healthcare professionals to make better diagnostic decisions, and lower healthcare costs.